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Abstract
Background Robust (inter-)national breast implant registries are important. For some, registries are an administrative burden, for
others they represent a solution for the discussions involving breast implants. The DBIR is one of the first national, opt-out,
clinical registries of breast implants, providing information for clinical auditing and product recall. Four years after its introduc-
tion, it is time to address users’ comments in order to keep improving quality of registration, and patient safety. This study
assesses users’ feedback focusing on importance of registration, logistics and user experience, and areas of improvement.
Methods In May 2018, a standardized online study–specific questionnaire was sent out to all members of the Netherlands
Society of Plastic Surgery. Descriptive statistics were reported in absolute frequencies and/or percentages.
Results A total of 102 members responded to the questionnaire (response rate, 24.2%). Of all respondents, 97.1% were actively
registering in DBIR. Respondents rated the importance of registration in DBIR as 8.1 out of 10 points. Ninety-one respondents
suggested improvements for the DBIR. All comments were related to registration convenience and provision of automatically
generated data.
Conclusions Respondents believe that registration is highly important and worth the administrative burden. However, we should
collectively keep improving accuracy, usability and sustainability of breast implant registries. The primary focus should be on the
user interface; on user friendliness, automation, and data reusability. These users’ responses function as a new incentive and
provide learning points that are easy to extrapolate to others who want to set up or improve breast implant registries.
Level of evidence: Not ratable.
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Introduction
Breast implants are one of the most commonly used medical
devices, classified as high-risk class III devices [1, 2].
Worldwide, approximately 5–10 million women have breast
implants [3]. In the Netherlands, approximately 3.0% of all
women between 20 and 70 years old carried a breast implant
in 2019 [2, 4].
Since their introduction, the adverse effects of breast im-
plants have been under debate, including the breast implant–
associated–anaplastic large cell lymphoma (BIA-ALCL) [5,
6]. Risks are usually calculated by determining denominator
data such as the total number of women with a breast implant.
However, this has shown to be a major challenge for one of
the most used implants in medicine, which underlines the
importance of robust and nationwide breast implant registries.
In the Netherlands, the Dutch Breast Implant Registry
(DBIR) was introduced in 2015 [7]. The DBIR is a national
opt-out and mandatory clinical registry that registers patient,
operation, and implant characteristics from all patients under-
going implantation and explantation of breast implants, and
breast tissue expanders. The registry provides information for
clinical auditing and it can be used to identify patients in case
of a hazard alert or product recall, using social security num-
bers. Data are entered either by batch uploads from the hospi-
tal patient files, via an online portal, or by paper forms which
are subsequently registered in the online portal. Registration
of breast implants in DBIR is mandatory for all board-certified
plastic surgeons in the Netherlands, and only board-certified
plastic surgeons are allowed to perform breast implant– or
breast tissue expander–based surgery.
Today, the DBIR is growing into a mature, opt-out registry
[8], and together with Sweden and Australia, it is one of the
three leaders in breast implant registration. In 2016, 89% of
the eligible number of institutions known by the Dutch Health
and Youth Care Inspectorate (IGJ) participated in registration
in the DBIR (95% of the hospitals, 78% of the private clinics)
[8]. By the start of 2018, 38,000 implants had been registered
in 18,000 women [8].
Even though stakeholders understand and appreciate the im-
portance of this registry [9], long-term funding commitments
remain a challenge and subject of discussion. In addition, regis-
tering data is time consuming for plastic surgeons (time spent by
the surgeon to register a revision case being approximately 5–10
min). This leads to questions, such as: “What do the users think
of the registry?”, “Do they find the registry important?”, “What
are current user experiences and what should we focus on to
improve ease of use?”. Four years after its introduction, it is time
to ask feedback from the users in order to move forward and
keep improving the quality of registration and patient safety.
Therefore, the aim of this study was to assess feedback of the
users focusing on 3 domains: (A) importance of registration, (B)
logistics and user experience, and (C) areas of improvement.
Material and methods
Design
In May 2018, a standardized online study–specific question-
naire was designed. After a pilot survey among the DBIR
committee was completed, the questionnaire was sent out by
email to all plastic surgeons and plastic surgery residents who
are members of the Netherlands Society of Plastic Surgery
(NVPC). The current study was centrally approved by the
scientific board of the DBIR, and the NVPC. Respondents
consented to the use of this data for anonymized publication.
The Medical Research Involving Human Subjects Act
(WMO) does not apply to this study.
Questionnaire
The online questionnaire covered three domains: (A) impor-
tance of registration, (B) logistics and user experience, and (C)
areas of improvement. Users were given the option to com-
plete a short or a long version of the questionnaire up to their
own preference. The short version included 9 or 12 questions
(dependent on whether the respondent indicated that he or she
personally enters data into DBIR), and the long version in-
cluded 16 or 18 questions. The survey consisted of open-
ended questions with space to enter free text, and closed ques-
tions. Closed questions were either multiple choice or required
a single answer.
Database and statistical analysis
The questionnaire was set up in SurveyMonkey®, an online
questionnaire collection program that conforms to the General
Data Protection Regulation (GDPR). Survey responses were
analyzed in a de-identified manner. Descriptive statistics were
reported in absolute frequencies and/or percentages.
Results
Demographics
All members of the NVPC (i.e., 422 plastic surgeons, plastic
surgery residents and physician assistants) were invited to
participate. A total of 102 members responded to the question-
naire (response rate, 24.2%). Of the respondents, 85 (83.3%)
were board-certified plastic surgeons, 15 (14.7%) were resi-
dents in plastic surgery and 2 (2.0%) were physician assistants
(Table 1). The long form was completed by 70 (68.7%) re-
spondents, and the short form by 32 (31.4%) respondents.
A total of 99 of 102 respondents (97.1%) were actively
registering in the DBIR. Respondents worked at 60 different
institutions in the Netherlands (Fig. 1). Thirty-two (31.4%)
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respondents worked at two or more types of medical centers
(e.g. academic hospital and private clinic). Twenty-one
respondents (20.6%) worked in an academic hospital, 73
(71.5%) in a non-academic hospital, and 44 (43.1%) in a pri-
vate clinic or independent treatment center (Table 1).
Importance of registration
On average, respondents rated the importance of registration
of breast implants in DBIR as 8.1 out of 10 points. None of the
respondents encountered patients who wished to opt-out the
registration of their breast implant(s).
A total of 97% of all respondents reported that they register
in the DBIR. Ninety-two respondents (90.2%) registered be-
cause of the national obligation for registration of medical
implants, 75 (73.5%) registered because registration is man-
datory for all board-certified plastic surgeons in the
Netherlands, 24 (23.5%) registered to support data collection
for the Dutch Health and Youth Care Inspectorate (i.e., these
Table 1 Characteristics of respondents
No. (%)
Types of healthcare institution
Academic 21 20.6
Non-academic 73 71.5
Private or independent treatment center 44 43.1
Two or more types 32 31.4
Role of respondent
Board-certified plastic surgeon 85 83.3
Plastic surgery resident 15 14.7
Physician assistant 2 2.0
Total respondents 102 100
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Ikazia Ziekenhuis Isala Jeroen Bosch Ziekenhuis
Kliniek Veldhoven Maasstad Ziekenhuis Martini Ziekenhuis
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Fig. 1 Number of respondents per participating center
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indicators are legally required for health care institutions and
aim to monitor the quality of care), and 24 (23.5%) to collect
benchmark information (Fig. 2). Other motivations to register
included increasing quality and safety (2.0%), recall purposes
(5.9%), and scientific research (2.0%).
Reasons for not registering included the following: (1)
Registration was done by the supervising surgeon, (2) not
being the main surgeon of the operation, or 3) not having
performed breast implant surgery.
Logistical challenges and user experiences
To gain insight into the different logistical and administrative
challenges of registration in the DBIR, a number of multiple-
choice questions were asked.
Who registers Of all responding plastic surgeons, 79 (77.5%)
registered their cases personally. Five respondents (4.9%) re-
ported that the case was either registered by a plastic surgeon
or by a resident (Fig. 3). For 23 respondents (22.5%), the
registration was performed by an administrative assistant, 12
respondents (11.8%) reported that either an operating nurse or
a physician assistant registered, and one respondent had a data
manager who registered in the DBIR.
When do users register Forty-four plastic surgeons (44.4%)
registered immediately after the operation (i.e. while still in
the operating room), 32 (32.3%) registered somewhere else at
a later moment (i.e. outside the operating room), and 23
(23.2%) registered sometimes immediately in the operating
room and sometimes somewhere else after the operation
(Fig. 4).
How do users register Most respondents (82, 80.4%) regis-
tered directly via the online portal system, of whom 6 (5.9% of
total respondents) sometimes registered through batch uploads
to DBIR via the electronic medical patient record (Fig. 5), 11
(10.8%) used the paper surveys first, and 1 (1.0%) used all the
different registration methods. Just 6 respondents (5.9%) sole-
ly filled out the paper surveys and 7 (6.9%) solely used batch
delivery to DBIR. Four respondents (3.9%) indicated to reg-
ister using either paper surveys or through batch delivery.
Two respondents (2.0%) did not answer this question.
The survey also quantified the awareness and use of the
GS1 barcode scanning technology. The GS1 is a technique to
provide a unique device identifier (UDI) to medical implants
that can be printed as a barcode. This way, breast implants can
be registered by scanning the functional Global Standards 1
(GS1) barcode field. This serves the purpose to (1) reduce
registration burden, (2) increase data quality by reducing typ-
ing errors, and (3) use this for automation of data points in the
future (Appendix 1). Only one plastic surgeon used the GS1
barcode scanner. Most of the respondents did not have a scan-
ner available, or it was not linked to the electronic medical
patient record.
Areas of improvement
Feedback for areas of improvement was asked in an open-
ended question. Ninety-one respondents (89.2%) suggested
improvements for the DBIR. In summary, the following sug-
gestions could be distinguished: (1) improve and simplify the
method of data import (e.g., by decreasing the amount of
questions or pre-loading data automatically through the elec-
tronicmedical record system for example), (2) obligate the use
of the GS1 barcode scanner, e.g., in order to decrease the
chance of typing errors, (3) automate monitoring of incom-
plete data, (4) make a clearer lay-out of the registration file, (5)
change the language of the registration to Dutch instead of
English, (6) provide reports and feedback, and (7) show auto-
mat ica l ly genera ted nat ional and local data for
comparison after login.
Discussion
Previous literature underscores the importance of national
breast implant registries in monitoring breast implant safety
[1, 9, 10]. Recently, the results of public hearings run by the
French ANSM, the Australian TGA, and the US FDA, in
response to the issues on textured implants and BIA-ALCL,
echo the advice to strictly register implant data. The present
study sought to evaluate the perspective of the surgeons who
are actually doing the registration and showed that surgeons
believe that registration of breast implants is highly important
(8.1 out of 10 points). This score can be translated as a ‘green
light’ to continue the registration.
90.2
73.5
23.5
23.5
9.9
0 10 20 30 40 50 60 70 80 90 100
National obligation of implant registration
Registration made manditory for board-certified plastic surgeons
Benchmark information
Other
%
To support datacollection for Dutch Health and Youth Care Inspectorate (IGJ)
Fig. 2 Reasons for registration
Eur J Plast Surg
The results of this paper should be interpreted in light of its
strengths and limitations. First, the survey was not a validated
survey; however, the authors did run a pilot survey among
fellow plastic surgeons from the DBIR committee. Second,
the response rate of the questionnaire was 24.2%. This may
have introduced nonresponse bias. For example, it might be an
overestimation that 97% percentage of the respondents regis-
ter and that they rate the importance of registration 8.1 out of
10 points, as surgeons who are supportive of the registry
might be more likely to complete the survey. The origin of
the respondents did show an equal spread in terms of their
geographical location across the country and their spreading
across different hospitals (Fig. 1). Although this study is lim-
ited to its geographical (Dutch) scope, we believe the users’
responses function as a new incentive and provide learning
points that are easy to extrapolate to others who want to set up
or improve breast implant registries.
Robust, (inter-)national breast implant registries are impor-
tant [11]. However, there is also criticism towards the exis-
tence of national breast implant registries. To enable valid data
comparisons not only nationally but also worldwide, DBIR
questions are based on the international standard set as de-
signed by the International Collaboration of Breast Registry
Activities (ICOBRA). Some believe registries could lead to
invalid or ‘bad’ data, because the data is manually entered by
the clinicians, and because the ICOBRA data set is not evi-
dence based. Consequently, this could lead to loss of informa-
tion about relevant characteristics [12]. In order to maintain
and improve the quality of data, yearly improvements are
made, quality control mechanisms are incorporated, and data
points are updated. For example, immediate feedback is pro-
vided on missing and unlikely data, a signaling list on missing
or erroneous data is added and since 2019, and a daily up-
dated, interactive dashboard is available with information
about patient characteristics and performances for participat-
ing institutions that show their outcomes compared to a Dutch
benchmark (Codman Dashboard) [13]. Another important
concern towards registration data is that it can be time con-
suming. By definition, a registry is dependent on physician
participation. Therefore, a balance between registration bur-
den, registration ease, and added value must always be delib-
erately considered when setting up a registry.
Also, when setting up a registry, individuals’ privacy and
national privacy laws should carefully be considered and
respected, as legislation can make registration difficult.
Differences in the interpretation of laws exist among health
77.5
4.9
27.5
22.5
6.9
4.9
1
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Other
%
Fig. 3 Who registers
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%
Fig. 4 When do we register
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care institutions and countries. In the Netherlands, for exam-
ple, the introduction of new privacy legislation puts clinical
quality registries under pressure. The new lawmay complicate
registration of citizen identification numbers, which makes it
even harder to trace the implant back to individual patients. In
order to comply with the General Data Protection Regulation
(GDPR), the DBIR works with a certified Trusted Third Party
(MRDM) to process the data [13]. The data which the DBIR
receives from MRDM cannot be traced back to individuals.
Since users already consider registration of breast implants
as highly important, the implant registration system should
focus on optimization of the register. Addressing users’ com-
ments is pivotal to keep users actively engaged and motivated.
Almost all surgeons, 89.1%, suggested several improvements
for the registry. This survey provides recommendations into
which areas such improvements are required. All comments
were related to registration convenience and provision of au-
tomatically generated (national and local) data. Considering
the fact that the registration process relies on adherence of
physicians’ participation, improvement of the registry’s user
friendliness by improving its user interface is first priority.
Automation of the registration process through the use of
bar code scanners, intelligent and automated data uploading,
and data point reduction are key to improve ease of use.
Ideally, this process should be embedded in the operating
room in order to support automated registration at the moment
of implantation.
Improving registration convenience is especially important
given the reasons why people register. As in any process, there
are ‘carrots’, the reward for an action, and there are ‘sticks’,
the punishment for not acting. In the case of the DBIR, the
‘carrots’ include having benchmarked data to measure an in-
stitutes’ or departments’ performance, generation of data that
supports scientific research to confirm breast implant safety
for patients, and a sense of ‘professional pride’. The ‘sticks’
on the other hand, include measures such as making registra-
tion a requirement for board registration or a national quality
indicator that is asked for by the Health Care Inspectorate, and
shared with the general public. From this survey, it appears
that ‘sticks’ are the most effective incentives that activate sur-
geons. Strikingly, the ‘carrots’, such as obtaining a bench
mark and scientific research, are of less interest. However,
we believe that better registration can also be reached by
instating more efficient ‘carrots’. Examples of this would in-
clude making the registry more functional, e.g. by automati-
cally transferring data on adverse events, having reduced in-
surance fees when a surgeon shows compliance, or follow the
Australian example by awarding physicians with professional
development points for compliance to registration [10].
Moreover, increasing the awareness of the importance of ad-
herence to the registration process by educating both col-
leagues and residents might further enhance physicians’
participation.
The DBIR aims to work with automated data entry tech-
nologies in order to improve data entry comfort, and data
quality in the future. For example, through registration with
catalog numbers and unambiguous registration at the source,
i.e., the electronic medical patient record (“Dutch: Registratie
aan de bron”), all implant and relevant patient data will auto-
matically be uploaded. Implementation of standard content,
e.g., by implementing Systemized Nomenclature of
Medicine–Clinical Terms (SNOMED CT), can support (in-
ter-)national comparability of data.
The value of the GS1 barcode scanner is widely
adopted; however, this survey showed that only one re-
spondent used the GS1 barcode scanner and that the
scanner was not available to most respondents.
Therefore, the DBIR committee is working on making
62.7
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5.9
6.9
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3.9
1
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0 10 20 30 40 50 60 70 80 90 100
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%
Fig. 5 How do we register
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the GS1 barcode scanner available to everyone. As a
result, more industrial suppliers are starting to include a
GS1-compatible barcode on their implant boxes. Also,
automatic content linking of the scanner to the electronic
medical patient records should be provided for all.
Modern ways of improving registries using artificial in-
telligence and machine learning, as incorporated in com-
puter science decades ago should be the future.
Multidisciplinary approaches with specialties outside the
hospital, such as data science companies, may lead to
useful new insights.
Today, the DBIR collects its data through either an
online portal system (Appendix 3), or through batch de-
livery to DBIR via the electronic medical patient record.
When registering through the online portal, surgeons are
able to choose to register on a paper questionnaire first
(Appendix 2). Eventually, the answers on the paper form
have to be entered in the online portal. The paper version
of the data points was designed to be used to fill out in a
‘tick and stick’ format in the operating room in order to
subsequently hand it over to, for example, an administra-
tive assistant to file the data points online. This was
thought to be useful in reducing the administrative burden
for the surgeon. However, this survey showed a clear
preference for direct manual entry of data in the secure
online portal (80.4%), and that only 21.6% filled out the
paper surveys. In support of data collection, various strat-
egies are being developed:
1. Automatic uploads from hospital files. This survey
showed that only a small portion of our data is now en-
tered though this route; however, in the future, we aim to
increase this use. In order to achieve this, leading hospital
record software builders should be encouraged to agree
on sharing templates between hospitals in a transparent
way.
2. Development of a global breast implant catalogue. A high
capture rate of reliable data at a national level that is in-
ternationally comparable through harmonized data sets is
essential [11]. A global breast implant catalogue will en-
able the system to upload all the implant-specific data by
entering the reference number of the implant. Moreover, it
would uniform data entry, whereas now bias is caused,
e.g., by users who are unaware of the texture gradient of
the implants.
Our most used online registration method of data col-
lection differs from the Australian Breast Device
Registry (ABDR). The ABDR ensures data collection
by collecting the paper forms filled out by the surgeons
or the department staff, and subsequently double-checks
and enters the paper data. Validation rules have been
built into this database, but a paper-based system for data
entry has several limitations: it may include incomplete
fields and challenging handwriting, it is susceptible for
transcription errors, and it is not environmentally friend-
ly. Therefore, only using a smart web portal or mobile
device system with adaptive pathways is considered pri-
ority in order to make registration easier, faster, and
more complete. This example shows how different na-
tional registries can learn from each other by comparing
experience and knowledge, in order to stimulate individ-
ual growth as well as international uniformity and com-
parability of data (quality).
Thus, in order to reach the best practice for our patients,
we should collectively keep working on improvement of
accuracy, usability, and sustainability of breast implant reg-
istries around the world. Mutual international collaborative
initiatives and collaboration between different specialties
will not only mitigate duplication of efforts of individuals
but also amplify data sets and thus enable to detect
implant-related problems at a much earlier stage [11]. One
would hope that the excitement from the results of these
DBIR user’s experiences instigate further enthusiasm for
the development of new national registries, and the expan-
sion and improvement of the existing ones. In the context
of this, discussion is of great importance within the world
of plastic surgeons. Therefore, we would like to encourage
those involved once more to publish about and to enter the
debate around implant registers and how we can build fur-
ther in a workable environment.
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Barcode field on implant box
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